Jose Chatkin

Dr. Jose Chatkin


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
JCJose Chatkin
Jose Chatkin
LCLiana Correa
Liana Correa
USUbiratan Santos
Ubiratan Santos

1 January 2007 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
LFLeandro Genehr Fritscher
Leandro Genehr Fritscher
CMCláudio Cora Mottin
Cláudio Cora Mottin
SCSimone Canani
Simone Canani
JCJose Chatkin
Jose Chatkin

28 February 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
USUbiratan de Paula Santos1
Ubiratan de Paula Santos1
3A3 Marcos Abdo Arbex2
3 Marcos Abdo Arbex2
4B4 Alfésio Luis Ferreira Braga3
4 Alfésio Luis Ferreira Braga3
RMRafael Futoshi Mizutani
Rafael Futoshi Mizutani
JCJosé Eduardo Delfini Cançado6
José Eduardo Delfini Cançado6
JCJose Chatkin
Jose Chatkin
Environmental air pollution is a major risk factor for morbidity and mortality worldwide. Environmental air pollution has a direct impact on human health, being responsible for an increase in the incidence of and number of deaths due to cardiopulmonary, neoplastic, and metabolic diseases; it also contributes to global warming and the consequent climate change associated with extreme events and environmental imbalances. In this review, we present articles that show the impact that exposure to different sources and types of air pollutants has on the respiratory system; we present the acute effects-such as increases in symptoms and in the number of emergency room visits, hospitalizations, and deaths-and the chronic effects-such as increases in the incidence of asthma, COPD, and lung cancer, as well as a rapid decline in lung function. The effects of air pollution in more susceptible populations and the effects associated with physical exercise in polluted environments are also presented and discussed. Finally, we present the major studies on the subject conducted in Brazil. Health care and disease prevention services should be aware of this important risk factor in order to counsel more susceptible individuals about protective measures that can facilitate their treatment, as well as promoting the adoption of environmental measures that contribute to the reduction of such emissions.

1 September 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMMilena Soriano Marcolino
Milena Soriano Marcolino
MPMagda C. Pires
Magda C. Pires
LRLucas Emanuel F. Ramos
Lucas Emanuel F. Ramos
RSRafael T. Silva
Rafael T. Silva
LOLuana M. Oliveira
Luana M. Oliveira
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
The majority of available scores to assess mortality risk of coronavirus disease 19 (COVID-19) patients in the emergency department have high risk of bias. Therefore, our aim was to develop and validate a score at hospital admission for predicting in-hospital mortality in COVID-19 patients, and to compare this score with other existing ones. Consecutive patients (≥18 years) with confirmed COVID-19 admitted to the participating hospitals were included. Logistic regression analysis was performed to develop a prediction model for in-hospital mortality, based on the 3978 patients admitted between March-July, 2020. The model was validated in the 1054 patients admitted during August-September, as well as in an external cohort of 474 Spanish patients. Median (25th-75th percentile) age of the model-derivation cohort was 60 (48-72) years, and in-hospital mortality was 20.3%. The validation cohorts had similar age distribution and in-hospital mortality. Seven significant variables were included in the risk score: age, blood urea nitrogen, number of comorbidities, C-reactive protein, SpO2/FiO2 ratio, platelet count and heart rate. The model had high discriminatory value (AUROC 0.844, 95% CI 0.829 to 0.859), which was confirmed in the Brazilian (0.859 [95% CI 0.833 to 0.885]) and Spanish (0.894 [95% CI 0.870 to 0.919]) validation cohorts, and displayed better discrimination ability than other existing scores. It is implemented in a freely available online risk calculator (https://abc2sph.com/). We designed and validated an easy-to-use rapid scoring system based on characteristics of COVID-19 patients commonly available at hospital presentation, for early stratification for in-hospital mortality risk of patients with COVID-19.

18 September 2017 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
JCJose Chatkin
Jose Chatkin
LZL. Zani-Silva
L. Zani-Silva
IFI. Ferreira
I. Ferreira
NZN. Zamel
N. Zamel

22 March 2016 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
NSNóris Scaglia
Nóris Scaglia
JCJose Chatkin
Jose Chatkin
KCKenneth R Chapman
Kenneth R Chapman
IFIvone Ferreira
Ivone Ferreira
MWMario Wagner
Mario Wagner
NZNoe Zamel
Noe Zamel
Omega3 polyunsaturated fatty acids (PUFAs) are related to several diseases, including smoking. The aim of this study was to evaluate the relationship between omega-3 intake and tobacco smoking, taking into account the qualitative differences in dietary intake between smokers and non-smokers, the amount of the ingested PUFA and their red blood (RBC) contents. We also looked for an association between omega-3 RBC content and smoking, and also between omega3 intake and the level of nicotine dependence. Using a cross-sectional study, we included 50 current smokers (group I) and 50 lifetime non-smokers (group II), aged 18–75 years. We screened them at the Toronto Western Hospital and the Centre for Addiction and Mental Health (Toronto, Canada). The subjects completed a questionnaire with demographic data, lifestyle habits and details of food intake. The PUFAs measured in the RBC membranes were alphalinolenic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid and docosahexaenoic acid (DHA). In order to perform an adjusted comparison between smokers and non-smokers we used the ANCOVA model. After adjusting for confounding factors, non-smokers showed higher consumption of PUFAs, especially salmon: 800 g (0–7.740) than smokers 430 g (0–2.150) P < 0.001. They also had higher DHA levels compared to smokers: 4.81 % (2.79–10.21) and 4.13 % (2.33–7.73), respectively, p < 0.05. The other PUFAs showed no significant differences between the two groups. Smokers ate less fish rich in omega3 fatty acids than non-smokers, showing and inverse and significant relationship between omega3 intake and smoking. Smokers had lower levels of DHA and EPA, a not previously reported finding. Considering that PUFAs probably interfere in smoking habit, the increase in omega-3 consumption may become a perspective in prevention or treatment of smoking. However, this inference must be evaluated through specific studies.